LncRNA and Gene expression profiling of human bladder cancer
Bladder cancer (BC) is the most common urologic neoplasms with a high rate of recurrence. The formation of BC is a complicated process, resulting from smoke, drugs, or bladder inflammation. However, the underlying mechanisms of BC tumorigenesis remained unclear. In this study, we performed microarray analysis of three paired paratumor (PT) and tumor tissues from BC patients. In comparison with PT, BC tissues displayed 1136 upregulated and 1199 downregulated lncRNAs, and 1347 upregulated and 953 downregulated mRNAs. In addition, the upregulated mRNAs were focused in SNARE interactions, amino sugar and nucleotide sugar metabolism, and antigen processing pathways. The common downregulated genes were mainly focused in amino acid metabolism and drug metabolism signaling. More importantly, cytokinerelated genes were highly expressed in BC, which suggest that the dysregulation of immunoregulatory process and amino acid metabolism played a crucial role in the oncogenesis of BC.
Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424 (2018).
Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J Clin 66, 115-132 (2016).
Marcos-Gragera, R. et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer 51, 2217-2230 (2015).
Morales, A., Eidinger, D. & Bruce, A. W. Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors *. Journal of Urology 167, 891-894 (1976).
Maase, H., Von Der et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology 18, 3068 (2000).
Janković, S. & Radosavljević, V. Risk factors for bladder cancer. Tumori 93, 4-12 (2007).
Akbani, R. et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171, págs. 540-556 (2017).
Choudhury, N. J. et al. Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer. Eur Urol Focus 2, 445-452 (2016).
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57 (2009).
Smith, S. G. & Zaharoff, D. A. Future directions in bladder cancer immunotherapy: towards adaptive immunity. Immunotherapy 8, 351-365 (2016).
Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nature Reviews Genetics 10, 155-159 (2009).
Anastasiadou, E., Jacob, L. S. & Slack, F. J. Non-coding RNA networks in cancer. Nat Rev Cancer 18, 5-18 (2018).
Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
Yang, F., Zhang, H., Mei, Y. & Wu, M. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol Cell 53, 88-100 (2014).
